Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

JB Pharma slashes price of critical Heart Failure medicine AZMARDA (Sacubitril-Valsartan) by nearly 50 percent

Ruchika Sharma5 Dec 2022 2:37 PM IST

"This move by JB will not only help reduce the cost of treatment but will also help enhance the productive years of patients and their quality of...

Sun Pharma, Dr Reddy's Labs recall products in US over manufacturing issues

Ruchika Sharma5 Dec 2022 1:30 PM IST

The health regulator further said the US-based arm of Sun Pharma is recalling 14,064 cartons of a medication to treat erosive esophagitis or heartburn...

Shilpa Medicare gets Health Canada GMP approval for Jadcherla facility

Ruchika Sharma5 Dec 2022 12:30 PM IST

Karnataka: Shilpa Medicare has recently announced that the Company's finished dosage form manufacturing facility, Unit IV, situated at Pharma...

Syngene acquires biologics site from Emergent BioSolutions arm for USD 36.5 million

Eli Lilly concludes acquisition of Akouos

Ruchika Sharma5 Dec 2022 11:30 AM IST

Indianapolis: Eli Lilly and Company has recently announced the successful completion of its acquisition of Akouos, Inc. "The acquisition...

GSK Depemokimab applications accepted for review in China, Japan for asthma with type 2 inflammation, CRSwNP

EMA validates marketing authorization application for blood cancer oral treatment Momelotinib: GSK

Ruchika Sharma5 Dec 2022 10:30 AM IST

Myelofibrosis is a rare blood cancer that results from dysregulated JAK-signal transducer and activator of transcription protein signalling and is...

Aurobindo Pharma arm Rajasthan facility gets 9 USFDA observations

Aurobindo pharma join hands with IMT Hyderabad to offer Certified Leadership Program

Ruchika Sharma4 Dec 2022 4:30 PM IST

The company has shortlisted 35 candidates from over 150 mid-level managers from across functions following a coherent process that included –...

Pfizer, Roivant form company to develop ulcerative colitis treatment

Ruchika Sharma4 Dec 2022 3:45 PM IST

Pfizer owns a 25% equity position in the Vant and maintains commercial rights outside of the US and Japan as well as representation on the company's...

Regeneron Pharma Evkeeza under USFDA priority review for children with Ultra-rare inherited form of high cholesterol

Ruchika Sharma4 Dec 2022 2:15 PM IST

Tarrytown: Regeneron Pharmaceuticals, Inc. has announced the U.S. Food and Drug Administration (USFDA) has accepted for Priority Review the...

BioNTech, Ryvu Therapeutics ink pact for Immuno-Modulatory Small Molecule Candidates

Ruchika Sharma4 Dec 2022 12:30 PM IST

Under the terms of the agreement, BioNTech will pay Ryvu an upfront fee of €20 million in exchange for certain rights to Ryvu’s STING agonist...

AstraZeneca gets USFDA approval for perioperative Imfinzi for bladder cancer

AstraZeneca to sell West Chester site to National Resilience

Ruchika Sharma4 Dec 2022 11:00 AM IST

AstraZeneca expects to complete the sale in the first quarter of 2023, with a phased transition of services.

COVID trials improved diversity recruiting, says Moderna Top Scientist

Ruchika Sharma3 Dec 2022 4:00 PM IST

New York: Moderna Inc's top scientist has said that the vaccine maker has learned how to better recruit from diverse populations for its clinical...

Merck gets USFDA Priority Review for application for Keytruda plus standard of care as Perioperative treatment for Resectable Locally Advanced Head, Neck Squamous Cell Carcinoma

Merck hopes to patent subcutaneous version of blockbuster cancer drug Keytruda

Ruchika Sharma3 Dec 2022 2:31 PM IST

Merck's patents on the subcutaneous version of Keytruda could protect that formulation until at least 2040, according to Tahir Amin, co-founder of...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok